A detailed history of Mackenzie Financial Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 14,826 shares of CPRX stock, worth $320,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,826
Previous 14,016 5.78%
Holding current value
$320,241
Previous $217,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.19 - $21.35 $12,303 - $17,293
810 Added 5.78%
14,826 $294,000
Q2 2024

Aug 14, 2024

BUY
$14.68 - $16.92 $205,754 - $237,150
14,016 New
14,016 $217,000
Q3 2022

Oct 07, 2022

SELL
$7.06 - $15.52 $3,360 - $7,387
-476 Reduced 0.85%
55,512 $712,000
Q2 2022

Aug 10, 2022

BUY
$6.23 - $8.57 $8,049 - $11,072
1,292 Added 2.36%
55,988 $392,000
Q1 2022

May 13, 2022

SELL
$5.31 - $8.31 $127,025 - $198,791
-23,922 Reduced 30.43%
54,696 $453,000
Q4 2021

Feb 14, 2022

BUY
$5.21 - $7.45 $409,599 - $585,704
78,618 New
78,618 $532,000
Q4 2020

Feb 10, 2021

SELL
$2.97 - $3.83 $32,373 - $41,747
-10,900 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.97 - $5.08 $32,373 - $55,372
10,900 New
10,900 $32,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.